A clinician's approach to medical management of obesity

American Journal of the Medical Sciences

Volumn 331, Issue 4, 2006, Pages 175-182

  Low, Annette K ^a   Bouldin, Marshall J ^a   Sumrall, Caryl D ^a   Loustalot, Fleetwood V ^a   Land, Kelly K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Medical weight loss; Obesity

Indexed keywords

PHENTERMINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ARTICLE; BARIATRIC SURGERY; BEHAVIOR MODIFICATION; DIARRHEA; DIET; DRUG TOLERANCE; ECONOMIC ASPECT; FECES INCONTINENCE; FLATULENCE; HUMAN; HYPERTENSION; INSOMNIA; LIFESTYLE; MORBID OBESITY; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; STEATORRHEA; TACHYCARDIA; WEIGHT REDUCTION; XEROSTOMIA;

ANTI-OBESITY AGENTS; BARIATRIC SURGERY; BEHAVIOR THERAPY; BODY MASS INDEX; DIET; DISEASE MANAGEMENT; EXERCISE; HUMANS; LIFE STYLE; OBESITY; WEIGHT LOSS;

EID: 33646404630     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200604000-00003     Document Type: Article

References (30)

1. National Centers for Health Statistics, Centers of Disease Control. Prevalence of overweight and obesity among adults: Unites States, 1999-2000. Washington, DC: National Centers for Health Statistics, Centers of Disease Control; Xxxx.
2. Flegal KM, Carroll MD, Odgen CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-7.
3. Finkelstein DA, Ruhm DJ, Kosa KM. Economic causes and consequences of obesity. Ann Rev Public Health 2005;26:239-57.
4. Knowler WC, Barrett-Conner E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
5. National Center for Health Statistics, Division of Data Services. Health, United States, 2002, with Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics, Division of Data Services; 2002.
6. Narbro K, Agren G, Jonsson E, et al. Pharmaceutical costs in obese individuals. Arch Intern Med 2002;162:2061-9.
7. Leese B. The costs of diabetes and its complications. Soc Sci Med 1992;35:1303-10.
8. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. NIH Publication No. 98-4083. Xxx: NIH; 1998.
9. McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: Summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003;139:933-49.
10. Lara MD, Kothari SN, Sugerman HJ. Surgical management of obesity: a review of the evidence relating health benefits to risks. Treat Endocrinol 2005;4:55-64.
11. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-200.
12. Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003;138:24-32.
13. Wadden TA, Foster GD, Letizia KA. One-year behavioral treatment of obesity: comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy. J Consult Clin Psychol 1994;62:165-71.
14. Volek JS, VanHeest JL, Forsythe CE. Diet and exercise for weight loss: a review of current issues. Sports Med 2005;35:1-9.
15. Balart LA. Diet options of obesity: fad or famous? Gastronenterol Clin North Am 2005;34:83-90.
16. Dansinger ML, Gleason JA, Griffith JL, et al. Comparison of Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction. JAMA 2005;293:43-53.
17. Tsai AG, Wadden TA. Systemic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med 2005;142:56-66.
18. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Surgeon General's Report on Physical Activity and Health. Atlanta, GA: CDC; 1996.
19. Redberg R, Greenland P, Fuster V, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease. Writing Group III: Risk assessment in persons with diabetes. Circulation 2002;105:e144-52.
20. Sullivan P, Morrato E, Ghushchyan V, et al. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 2005;28:1599-603.
21. Marrero D. Time to get moving: helping patients with diabetes adopt exercise as part of a healthy lifestyle. Clinical Diabetes 2005;23:154-9.
22. Persinger R, Foster C, Gibson M, et al. Consistency of the Talk Test for exercise prescription. Med Sci Sports Exerc 2004;36:1632-6.
23. American Diabetes Association, North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Weight management using lifestyle modifications in the prevention and management of Type 2 Diabetes: Rationale and strategies. Clin Diabetes 2005;23:130-6.
24. Bassuk S, Manson J. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol 2005;99:1193-1204.
25. LaMonte M, Blair S, Church T. Physical activity and diabetes prevention. J Appl Physiol 2005;99:1205-13.
26. Jakicic J, Otto A. Physical activity considerations for the treatment and prevention of obesity. Am J Clin Nutr 2005;82:226S-9S.
27. Lee S, Kuk J, Davidson L, et al. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without type 2 diabetes. J Appl Physiol 2005;99:1220-5.
28. Miller WC, Koceja DM, Hamilton EJ. A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention. Int J Obes Relat Metab Disord 1997;21:941-7.
29. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005;142:532-46.
30. Hill JO, Thompson H, Wyatt H. Weight maintenance: what's missing? J Am Diet Assoc 2005;105:S63-6.